ClinLabNavigator Logo
Analyzing Samples
Available Test Interpretations
C1 Esterase Inhibitor
C Reactive Protein
C Reactive Protein High Sensitivity
CA 125
CA 153
CA 19.9
CA 27.29
Caffeine
Calcitonin
Calcium
Calcium Ionized
Carbamazepine
Carbon Dioxide
Carbon Monoxide
Carcinoembryonic Antigen
Cardiac Marker Panel
Cardiovascular Risk Panel
Carotene
CCP Antibody
CD4 Enumeration
Celiac Disease Panel
Centromere Antibody
Cephalothin Antibody
Cerebrospinal Fluid
Ceruloplasmin
Chemistry Panels
Chlamydia Detection
Chloride
Cholesterol
Cholinesterase
Clindamycin Resistance
Clostridium Difficile
Coagulation Factor Assays
Coagulation Factor Inhibitor
Coagulation Screen
Cold Agglutinin Titer
Colloid Osmotic Pressure
Complement Profile
Complete Blood Count
Congenital Adrenal Hyperplasia
Cord Blood Gases
Cord Blood Studies
Corticotropin Releasing Hormone Stimulation Test
Cortisol
Cortisol in Critical Illness
Cortisol Salivary
Cortisol Urine Free
Cortrosyn Stimulation Test
Cotinine
Creatine Kinase
Creatine Kinase MB
Creatinine
Creatinine Clearance
Creatinine Kinase Isoenzymes
Crossmatch
CRP
Cryoglobulin
Cryptococcal Antigen
Cryptosporidium Antigen
Crystal Identification
Cushing Syndrome
Cyclosporine
Cystic Fibrosis
Cytogenetic Studies
Cytomegalovirus Antibody
Cytomegalovirus Culture
Cytomegalovirus PCR Qualitative
Cytomegalovirus PCR Quantitative
Test Interpretations
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Creatinine Kinase Isoenzymes

Print This Page
E-mail This Page

Creatine kinase (CK) is an enzyme that catalyzes the reversible phosphorylation of creatine by ATP. The end product, phosphocreatine, is a readily available energy source for cells. CK is present in many tissues but skeletal and heart muscles contain the highest concentrations. CK released from skeletal muscle accounts for almost all of the CK activity detected in the plasma of healthy individuals. Circulating CK is cleared by degradation in the liver and reticuloendothelial system and has a circulating half-life of 12 hours. Occasionally, measurement of CK isoenzymes may be helpful in elucidating the origin of an unexplained or persistently elevated total CK.



CK is composed of two subunits, CK-M (muscle type) and CK-B (brain type), which are combined into three distinct isoenzymes: CK-MM, CK-MB, and CK-BB. These isoenzymes can be separated and measured by electrophoresis. The following table illustrates the isoenzyme composition of different tissues.

Tissue

CK-3 (MM) (%)

CK-2 (MB) (%)

CK- 1 (BB) (%)

Brain

0

0

100

Heart

60-80

20-40

0

Skeletal muscle

96-100

0-4

0



Brain tissue contains predominantly CK1 (BB) and skeletal muscle contains almost exclusively CK3 (MM). The myocardium contains approximately 70% of CK3 (MM) and 30% of CK2 (MB).



CK-1 (BB) can be elevated in patients with head injury, in neonates, and in some cancers such as prostate cancer and small cell carcinoma of the lung.

CK-2 (MB) appears in serum 4 to 6 hours after the onset of pain in an MI, peaks at 18 to 24 hours, and returns to normal by 72 hours. CK-MB may also be elevated in cases of carbon monoxide poisoning, pulmonary embolism, hypothyroidism, crush injuries, and muscular dystrophy. Extreme elevations of CK-MB can be associated with skeletal muscle cell turnover as in polymyositis, and to a lesser degree in rhabdomyolysis.

Besides the 3 CK isoenzymes, electrophoresis can also detect 2 types of macro-CK. Macro-CK Type I is a complex of immunoglobulin, usually IgG, and CK-BB that migrates between CK-MM and CK-MB. It occurs primarily in elderly women and causes a persistent elevation of plasma CK activity because the large complex is not cleared. Macro-CK Type II represents Mitochondrial CK that migrates slightly cathodic of MM. It is usually only detected in severely ill patients with liver disease, malignancies or hypoxic injury.